Company profile - Brighter Actiste feature image - 16092019 - JPG

Brighter

OMX: BRIG

Market CapSEK327m

Last Close SEK0.84

Brighter is a Swedish healthtech company addressing common welfare challenges of modern society through a group of innovation companies. Its lead solution, Actiste, currently being commercialised, is aimed at helping people with diabetes adhere to care guidelines and achieve treatment goals.

More Brighter content >

Investment summary

Brighter is a healthtech company developing solutions for chronic diseases. Its initial strategy is the market introduction of Actiste, a remote monitoring and treatment service for diabetes which received two CE marks (Actiste is regulated under both the EU Medical Devices Directive and the In Vitro Diagnostics Directive) as well as regulatory approvals in Saudi Arabia, the United Arab Emirates and Thailand). The service includes a unique patented device that integrates all the essential features for daily diabetes management, a blood glucose meter, a lancer and an insulin injection pen, into a single unit with built-in mobile connection, and a digital platform for analysing and sharing data with family and friends, healthcare providers and other relevant stakeholders.

Y/E Dec
Revenue (SEKm)
EBITDA (SEKm)
PBT (SEKm)
EPS (öre)
P/E (x)
P/CF (x)
2019A 3.3 (73.7) (88.7) (105.85) N/A N/A
2020A 14.1 (158.6) (240.6) (117.74) N/A N/A
2021E 41.0 (119.3) (170.7) (51.68) N/A N/A
2022E 218.0 25.3 (27.0) (7.54) N/A 15.8
Industry outlook

In 2019, it is estimated that US$760bn (10% of total global healthcare expenditure) was spent on diabetes.

Last updated on 21/09/2021
Content on Brighter
Brighter – Poised for revenue momentum
Healthcare | Update | 21 May 2021
Company profile - Brighter Actiste feature image - 16092019 - JPG
Brighter – Progress in multiple regions
Healthcare | Update | 8 March 2021
Company profile - Brighter Actiste feature image - 16092019 - JPG
Brighter – Approvals in the UAE and Saudi Arabia
Healthcare | Update | 24 November 2020
Company profile - Brighter Actiste feature image - 16092019 - JPG
View more
Register to receive research on Brighter as it is published
Share price graph
Balance sheet
Forecast net debt (SEKm) 135
Forecast gearing ratio (%) 65
Price performance
%
1m
3m
12m
Actual (37.4) (33.4) (70.0)
Relative* (34.4) (35.5) (77.7)
52-week high/low SEK3.2/SEK0.8
*% relative to local index
Key management
Christer Trägårdh Chairman
Christopher Robinson Acting CFO
Erik Lissner Interim CEO
Marie-Louise Kanon Head of communication and brand